Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : National Health and Safety Corporation (OTC BB:NHLT) -- Ignore unavailable to you. Want to Upgrade?

To: westpacific who wrote (84)	2/9/1999 9:40:00 PM
From: RSkarsten	Respond to of 409

Glenn, I had exactly the same questions a month ago when I called the company. They were having some difficultly but solved it by selling several blocks of restricted shares to private investors. These shares will not be tradable on the common market for 1 year. My guess is Jan 1 2000. In any event, financing will also be announced very soon. They have already announced progress in financing, as well as interest from several Fortune 500 companies. See previous releases for details. This weekend looks like it might be the time for NHLT Russ

To: westpacific who wrote (84)	2/9/1999 9:42:00 PM
From: jdcpa	Read Replies (1) \| Respond to of 409

National Health & Safety Corporation Announces Financing for Marketing of Cancer Detection & POWERx Contracts WARMINSTER, Pa., Jan. 6 /PRNewswire/ -- National Health and Safety Corporation (OTC Bulletin Board:NHLT - news) announced today that it has entered into final stages of negotiations with PanAmerican BanCorp (OTC Bulletin Board: PRWT - news) of New York to provide up to $6 million in expansion financing. Dr. Dennis Bowers, President and CEO of National Health & Safety Corporation, indicated that the expansion financing will be utilized to service about $125 million in current contracts for its POWERx Medical Benefits Network and for marketing the Longport Soft Tissue Scanner, a device which is currently being tested for detecting various forms of cancer without the need for invasive surgical biopsies. National Health & Safety recently announced that it has acquired the exclusive North American marketing rights to the cancer detection technology of Longport. Bowers indicated that NHS projects revenues of about $100 million per year from the Longport technology, which he expects to be submitted to the FDA during the next 90 days. National Health & Safety is currently sponsoring clinical research into the applications of the Longport technology for cancer detection at Thomas Jefferson University Hospital in Philadelphia, PA.